JUN and non-small cell lung carcinoma: The network analysis of 79 key targets of SH003 in NSCLC treatment revealed TP53, JUN, AKT1, STAT3, and MAPK3 as the top five key targets with the higher value of degree, betweenness centrality, closeness centrality.